EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, ATAI: Atai Life Sciences N.V.

30 Dec 25 13:29
LAST:

4.015

CHANGE:
 0.02		OPEN:
3.990		HIGH:
4.040		ASK:
6.000		VOLUME:
1.67M
CHG(%):
0.38		PREV:
4.000		LOW:
3.900		BID:
0.010		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
30 Dec 253.9904.0403.9004.0151.67M
29 Dec 254.0004.1003.9604.0002.58M
26 Dec 254.2004.2004.0204.0703.03M
24 Dec 254.3404.3604.1104.1901.96M
23 Dec 254.4204.7204.2504.3306.67M
22 Dec 254.0604.3103.9204.3104.04M
19 Dec 253.9404.0153.9103.9609.99M
18 Dec 254.0904.2113.8803.9102.42M
17 Dec 254.2404.3344.0504.0601.44M
16 Dec 254.1004.2504.0804.2301.35M

PROFILE

Name:Atai Life Sciences N.V.
About:Atai Life Sciences N.V., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of mental health treatments in the United States, Germany, and Canada. The company develops BPL-003, an intranasal formulation of the benzoate salt form of mebufotenin that is in Phase 2a and 2b clinical studies for treatment resistant depression (TRD) and alcohol use disorder; RL-007, an orally bioavailable compound, which is a pro-cognitive neuromodulator in Phase 2b trial for cognitive impairment associated with schizophrenia; and ELE-101, a serotonergic psychedelic in Phase 2a trial for the treatment of major depressive disorder. It is also developing VLS-01, an oral transmucosal film formulation of N,N-Dimethyltryptamine in Phase 2 clinical study to treat TRD; EMP-01, an oral formulation of R-3,4-methylenedioxy-methamphetamine that is in Phase 2 clinical study for social anxiety disorder; and EGX-A & EGX-B, which are non-hallucinogenic 5-HT2A receptor agonists in preclinical studies for TRD. In addition, the company offers COMP360 for psilocybin therapy; and GRX-917 for the treatment of anxiety, depression, and various neurological disorders. ATAI Life Sciences N.V. was founded in 2018 and is headquartered in Amstelveen, The Netherlands.
Sector:Healthcare
Industry:Biotechnology
Address:Prof. J.H. Bavincklaan 7, Amstelveen, Netherlands, 1183 AT
Website:https://atai.com
CIK:0001840904
ISIN:NL0015000DX5
FIGI:BBG0107FR3K9

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

TECHNICAL INDICATORS

MA5:4.122.6%
MA10:4.112.3%
MA20:4.194.3%
MA50:4.5212.6%
MA100:4.6916.8%
MA200:3.4317.0%
STO9:12.96 
STO14:12.96 
RSI14:38.32 
WPR14:-79.41
MTM14:-0.32
ROC14:-0.07 
ATR:0.24 
Week High:4.7217.6%
Week Low:3.902.9%
Month High:4.7217.6%
Month Low:3.7117.0%
Year High:6.7568.1%
Year Low:1.15249.1%
Volatility:16.07